Zemuron and Insulin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zemuron (rocuronium bromide) and Insulin (insulin pork). Common drug interactions include septic shock among females and hyperthermia malignant among males.

The phase IV clinical study analyzes what interactions people have when they take Zemuron and Insulin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Zemuron?

Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.

What is Insulin?

Insulin has active ingredients of insulin pork. It is often used in diabetes. eHealthMe is studying from 50,203 Insulin users. Check the latest studies of Insulin.



On Jul, 20, 2026

20 people who take Zemuron and Insulin together, and have interactions are studied.

Zemuron and Insulin drug interactions.

What are the common drug interactions of Zemuron and Insulin, by gender? *:

female:

  1. Septic shock (shock due to blood infection)
  2. Apnoea (suspension of external breathing)
  3. Paralysis
  4. Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Upper respiratory tract infection
  7. Anaemia (lack of blood)
  8. Blood pressure fluctuation
  9. Death
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Hyperthermia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions)
  2. Alanine aminotransferase increased
  3. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  4. Cardiac arrest
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Zemuron and Insulin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Apnoea (suspension of external breathing)
  2. Paralysis

20-29:

  1. Hyperthermia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions)

30-39:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Splenic infarction (tissue damage of spleen)
  3. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  4. Anaemia (lack of blood)

40-49:

  1. Acute respiratory distress syndrome
  2. Asthenia (weakness)
  3. Cough
  4. Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
  5. Pneumonia
  6. Septic shock (shock due to blood infection)
  7. Upper respiratory tract infection
  8. Anaemia (lack of blood)
  9. Brain injury
  10. Hypoxia (low oxygen in tissues)

50-59:

  1. Death
  2. Drug effect decreased
  3. Multi-organ failure (multisystem organ failure)
  4. Renal failure acute (rapid kidney dysfunction)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Blood pressure fluctuation
  3. Generalised oedema (swelling all over the body)
  4. Hypersensitivity
  5. Hypotension (abnormally low blood pressure)
  6. Hypoxia (low oxygen in tissues)
  7. Joint swelling
  8. Laryngeal oedema (swelling of larynx)
  9. Local swelling (swelling at the site of some application of substance or injury)
  10. Localised intraabdominal fluid collection (collection of fluid in abdomen in single site)

What are the existing conditions these people have? *

  1. Neuromuscular Blockade Reversal: 4 people, 20.00%
  2. Fever: 3 people, 15.00%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 15.00%
  4. Type 2 Diabetes: 3 people, 15.00%
  5. High Blood Pressure: 3 people, 15.00%
  6. Pain: 3 people, 15.00%
  7. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 10.00%
  8. Dehydration (dryness resulting from the removal of water): 2 people, 10.00%
  9. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 10.00%
  10. Constipation: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zemuron and Insulin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zemuron and Insulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zemuron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Insulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zemuron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Insulin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rocuronium bromide and insulin pork (the active ingredients of Zemuron and Insulin, respectively), and Zemuron and Insulin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: